Subviral Dense Bodies of Human Cytomegalovirus Induce an Antiviral Type I Interferon Response

Cells. 2022 Dec 13;11(24):4028. doi: 10.3390/cells11244028.

Abstract

(1) Background: Cells infected with the human cytomegalovirus (HCMV) produce subviral particles, termed dense bodies (DBs), both in-vitro and in-vivo. They are released from cells, comparable to infectious virions, and are enclosed by a membrane that resembles the viral envelope and mediates the entry into cells. To date, little is known about how the DB uptake influences the gene expression in target cells. The purpose of this study was to investigate the impact of DBs on cells, in the absence of a viral infection. (2) Methods: Mass spectrometry, immunoblot analyses, siRNA knockdown, and a CRISPR-CAS9 knockout, were used to investigate the changes in cellular gene expression following a DB exposure; (3) Results: A number of interferon-regulated genes (IRGs) were upregulated after the fibroblasts and endothelial cells were exposed to DBs. This upregulation was dependent on the DB entry and mediated by the type I interferon signaling through the JAK-STAT pathway. The induction of IRGs was mediated by the sensing of the DB-introduced DNA by the pattern recognition receptor cGAS. (4) Conclusions: The induction of a strong type I IFN response by DBs is a unique feature of the HCMV infection. The release of DBs may serve as a danger signal and concomitantly contribute to the induction of a strong, antiviral immune response.

Keywords: IRGs; dense bodies; human cytomegalovirus; interferon-regulated genes; interferon-β; subviral particles.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents
  • Cytomegalovirus* / genetics
  • Endothelial Cells
  • Humans
  • Interferon Type I*
  • Janus Kinases
  • STAT Transcription Factors
  • Signal Transduction / genetics

Substances

  • Interferon Type I
  • Janus Kinases
  • STAT Transcription Factors
  • Antiviral Agents

Grants and funding

This research was funded by the Wilhelm Sander-Stiftung, grant numbers 2016.115.1 and 2020.003.1.